A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer
结合计算和功能分析的方法发现,IGF2BP2是多种结直肠癌临床前模型中化疗耐药性的驱动因素。
期刊:Molecular Cancer
影响因子:27.7
doi:10.1186/s12943-023-01787-x
Sandra Kendzia ,Susanne Franke ,Tarek Kröhler ,Nicole Golob-Schwarzl ,Caroline Schweiger ,Anna M Toeglhofer ,Christina Skofler ,Stefan Uranitsch ,Amin El-Heliebi ,Julia Fuchs ,Andreas Punschart ,Philipp Stiegler ,Marlen Keil ,Jens Hoffmann ,David Henderson ,Hans Lehrach ,Marie-Laure Yaspo ,Christoph Reinhard ,Reinhold Schäfer ,Ulrich Keilholz ,Christian Regenbrecht ,Rudolf Schicho ,Peter Fickert ,Sigurd F Lax ,Frank Erdmann ,Marcel H Schulz ,Alexandra K Kiemer ,Johannes Haybaeck ,Sonja M Kessler